Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 04/21
Trade details
- Type
- Insider sale
- Amount
- $965,318.31
- Shares · price
- 1,683 sh · $573.57 a share
- Held after
- 47,353 sh
- Trade date
- 26/04/20
- Filed
- 26/04/21
- Days to filing
- 1 days
Sold 3.4% of holdings
- Share of holding sold
- 3.4%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 03/21~05/20Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 planUnited Therapeutics
UTHR
$113.3M
209,000 sh
$113.3M
Filed 10/01
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29